Drastic reduction in the luminal Ca2+-binding proteins calsequestrin and sarcalumenin in dystrophin-deficient cardiac muscle

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1689, Issue 3, 2004, Pages 252-258

  Lohan, James ^a   Ohlendieck, Kay ^a  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

calsequestrin; Calsequestrin; Cardiomyopathy; CSQ; DMD; Dp427; Duchenne muscular dystrophy; Dystrophin; full length dystrophin isoform of 427 kDa; histidine rich calcium binding protein; HRCBP; mdx; Muscular dystrophy; Sarcalumenin

Indexed keywords

CALCIUM BINDING PROTEIN; CALSEQUESTRIN; DYSTROPHIN; HEART MUSCLE EXTRACT; PHENOBARBITAL; PROTEIN; SARCALUMENIN; UNCLASSIFIED DRUG;

ARTICLE; CALCIUM BINDING; CALCIUM TRANSPORT; CONTROLLED STUDY; HEART MUSCLE CELL; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; LONGITUDINAL STUDY; MUSCULAR DYSTROPHY; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BINDING; REDUCTION; X CHROMOSOME LINKAGE;

ANIMALS; BLOTTING, WESTERN; CALSEQUESTRIN; DYSTROPHIN; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MUSCULAR DYSTROPHY, ANIMAL; MYOCARDIUM;

EID: 3242778524     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbadis.2004.04.002     Document Type: Article

References (42)

1. Muntoni F., Torelli S., Ferlini A. Dystrophin and mutations: one gene, several proteins, multiple phenotypes. Lancet Neurol. 2:2003;731-740
2. Finsterer J., Stollberger C. The heart in human dystrophinopathies. Cardiology. 99:2003;1-19
3. Anderson J.L., Head S.L., Rae C., Morley J.W. Brain function in Duchenne muscular dystrophy. Brain. 125:2002;4-13
4. Ahn A.H., Kunkel L.M. The structural and functional diversity of dystrophin. Nat. Genet. 3:1993;283-291
5. Ohlendieck K., Matsumura K., Ionasescu V.V., Towbin J.A., Bosch E.P., Weinstein S.L., Sernett S.W., Campbell K.P. Duchenne muscular dystrophy: deficiency of dystrophin-associated proteins in the sarcolemma. Neurology. 43:1993;795-800
6. Ohlendieck K. Towards an understanding of the dystrophin-glycoprotein complex: linkage between the extracellular matrix and the membrane cytoskeleton in muscle fibers. Eur. J. Cell Biol. 69:1996;1-10
7. Campbell K.P. Three muscular dystrophies: loss of cytoskeleton- extracellular matrix linkage. Cell. 80:1995;675-679
8. Alderton J.M., Steinhardt R.A. How calcium influx through calcium leak channels is responsible for the elevated levels of calcium-dependent proteolysis in dystrophic myotubes. Trends Cardiovasc. Med. 10:2000;268-272
9. Alderton J.M., Steinhardt R.A. Calcium influx through calcium leak channels is responsible for the elevated levels of calcium-dependent proteolysis in dystrophic myotubes. J. Biol. Chem. 275:2000;9452-9460
10. + channels. Proc. Natl. Acad. Sci. U. S. A. 97:2000;4950-4955
11. Gillis J.M. Membrane abnormalities and Ca homeostasis in muscles of the mdx mouse, an animal model of the Duchenne muscular dystrophy: a review. Acta Physiol. Scand. 156:1996;397-406
12. Culligan K., Banville N., Dowling P., Ohlendieck K. Drastic reduction of calsequestrin-like proteins and impaired calcium binding in dystrophic mdx muscle. J. Appl. Physiol. 92:2002;435-445
13. Dowling P., Doran P., Ohlendieck K. Drastic reduction of sarcalumenin in Dp427-deficient fibres indicates that abnormal calcium handling plays a key role in muscular dystrophy. Biochem J. 379:2004;479-488
14. Dowling P., Lohan J., Ohlendieck K. Comparative analysis of Dp427-deficient mdx tissues shows that the milder dystrophic phenotype of extraocular and toe muscle fibres is associated with a persistent expression of beta-dystroglycan. Eur. J. Cell Biol. 82:2003;222-230
15. Emery A.E. The muscular dystrophies. Lancet. 359:2002;687-695
16. Muntoni F. Cardiomyopathy in muscular dystrophies. Curr. Opin. Neurol. 16:2003;577-583
17. Cox G.F., Kunkel L.M. Dystrophies and heart disease. Curr. Opin. Cardiol. 12:1997;329-343
18. Bulfield G., Silver W.G., Wight P.A.L., Moore K.J. X-chromosome-linked muscular dystrophy (mdx) in the mouse. Proc. Natl. Acad. Sci. U. S. A. 81:1984;1189-1192
19. Sicinski P., Geng Y., Ryder-Cook A.S., Barnard E.A., Darlison M.G., Barnard P.J. The molecular basis of muscular dystrophy in the mdx mouse: a point mutation. Science. 244:1989;1578-1580
20. Chu V., Otero J.M., Lopez O., Sullivan M.F., Morgan J.P., Amende I., Hampton T.G. Electrocardiographic findings in mdx mice: a cardiac phenotype of Duchenne muscular dystrophy. Muscle Nerve. 26:2002;513-519
21. Sapp J.L., Bobet J., Howlett S.E. Contractile properties of myocardium are altered in dystrophin-deficient mdx mice. J. Neurol. Sci. 142:1996;17-24
22. Bridges L.R. The association of cardiac muscle necrosis and inflammation with the degenerative and persistent myopathy of MDX mice. J. Neurol. Sci. 72:1986;147-157
23. Bia B.L., Cassidy P.J., Young M.E., Rafael J.A., Leighton B., Davies K.E., Radda G.K., Clarke K. Decreased myocardial nNOS, increased iNOS and abnormal ECGs in mouse models of Duchenne muscular dystrophy. J. Mol. Cell. Cardiol. 31:1999;1857-1862
24. Murray B.E., Ohlendieck K. Cross-linking analysis of the ryanodine receptor and alpha1-dihydropyridine receptor in rabbit skeletal muscle triads. Biochem. J. 324:1997;689-696
25. Dunn M.J., Bradd S.J. Separation and analysis of membrane proteins by SDS-polyacrylamide gel electrophoresis. Methods Mol. Biol. 19:1993;203-210
26. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. U. S. A. 76:1979;4350-4354
27. Harmon S., Froemming G.R., Leisner E., Pette D., Ohlendieck K. Low-frequency stimulation of fast muscle affects the abundance of Ca(2+)-ATPase but not its oligomeric status. J. Appl. Physiol. 90:2001;371-379
28. Froemming G.R., Ohlendieck K. Native skeletal muscle dihydropyridine receptor exists as a supramolecular triad complex. Cell. Mol. Life Sci. 58:2001;312-320
29. Leberer E., Timms B.G., Campbell K.P., MacLennan D.H. Purification, calcium binding properties, and ultrastructural localization of the 53,000- and 160,000 (sarcalumenin)-dalton glycoproteins of the sarcoplasmic reticulum. J. Biol. Chem. 265:1990;10118-10124
30. Ohkura M., Furukawa K., Fujimori H., Kuruma A., Kawano S., Hiraoka M., Kuniyasu A., Nakayama H., Ohizumi Y. Dual regulation of the skeletal muscle ryanodine receptor by triadin and calsequestrin. Biochemistry. 37:1998;12987-12993
31. Hidalgo C., Donoso P. Luminal calcium regulation of calcium release from sarcoplasmic reticulum. Biosci. Rep. 15:1995;387-397
32. MacLennan D.H., Reithmeier R.A. Ion tamers. Nat. Struct. Biol. 5:1998;409-411
33. Yano K., Zarain-Herzberg A. Sarcoplasmic reticulum calsequestrins: structural and functional properties. Mol. Cell. Biochem. 135:1994;61-70
34. 2+-binding protein from sarcoplasmic reticulum. Arch. Biochem. Biophys. 251:1986;369-378
35. Rohman M.S., Emoto N., Takeshima Y., Yokoyama M., Matsuo M. Decreased mAKAP, ryanodine receptor, and SERCA2a gene expression in mdx hearts. Biochem. Biophys. Res. Commun. 310:2003;228-235
36. 2+-binding protein of sarcoplasmic reticulum that contains highly conserved repeated elements. J. Biol. Chem. 264:1989;18083-18090
37. 2+ binding protein). Biochem. Biophys. Res. Commun. 300:2003;192-196
38. 2+ release channels. Int. Rev. Cytol. 183:1998;185-270
39. Protasi F. Structural interaction between RYRs and DHPRs in calcium release units of cardiac and skeletal muscle cells. Front. Biosci. 7:2002;D650-D658
40. Cannell M.B., Soeller C. Sparks of interest in cardiac excitation-contraction coupling. Trends Pharmacol. Sci. 19:1998;16-20
41. Leong P., MacLennan D.H. Complex interactions between skeletal muscle ryanodine receptor and dihydropyridine receptor proteins. Biochem. Cell. Biol. 76:1998;681-694
42. MacLennan D.H., Asahi M., Tupling A.R. The regulation of SERCA-type pumps by phospholamban and sarcolipin. Ann. N.Y. Acad. Sci. 986:2003;472-480